Patient Enrollment Marketing for Phase II Parkinson's Disease Study

February 9, 2018

 

Challenge

Enrollment for this 60-patient study had been underway for one year with 35 subjects enrolled. The sponsor had a 90-day deadline for randomizing the remaining 25 subjects.

Solution

ThreeWire worked with five carefully selected sites to identify a mix of "known" and "unknown" study candidates through chart reviews and highly targeted radio and print advertisements. All candidates were screened by our Patient Interaction Center® nurses. Those who passed pre-screening were invited with caregivers to attend a ThreeWire Community Health Talk®, where the respective investigator delivered a presentation base on informed consent. Interested participants were offered the opportunity for site screening.

Results

Following a 30-day startup period, 5 CHTs were conducted over a 10-day period. Out of a total of 75 attendees, 25 subjects were consented and randomized prior to the 90-day deadline.

Previous Flipbook
Patient Enrollment Marketing for Phase II Constipation Drug
Patient Enrollment Marketing for Phase II Constipation Drug

Challenge This study was open to enrollment for 4 months, but was significantly behind the projected enroll...

Next Flipbook
Patient Enrollment Marketing for Uterine Fibroids Study
Patient Enrollment Marketing for Uterine Fibroids Study

Launch a direct-to-patient marketing campaign for a medical device therapy used to treat uterine fibroids a...